What is relapsed or refractory MCL?

Although mantle cell lymphoma (MCL) usually responds well to initial treatment, patients do tend to relapse or become refractory. The term “relapsed” refers to disease that reappears or grows again after a period of remission. The term “refractory” describes when the lymphoma doesn't respond to treatment (meaning that the cancer cells continue to grow) or when the response to treatment doesn't last very long. It's normal to be concerned about relapsed or refractory MCL, but for patients who relapse or become refractory, secondary therapies may be successful in providing another remission.

Was this question helpful?

Thank you for your feedback.